| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |